BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3913944)

  • 1. [Preventive pharmacological procedures in peptic ulcer].
    Stasiewicz J; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1460-4. PubMed ID: 3913944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current concepts of the treatment of patients with peptic ulcer].
    Miagkova LP
    Klin Med (Mosk); 1991 Sep; 69(9):113-8. PubMed ID: 1687074
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
    Sakai M
    Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of peptic ulcer with gastrozepin].
    Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; El'tsova NB; Elisova NV
    Sov Med; 1984; (1):48-51. PubMed ID: 6546622
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of stress ulcer in intensive care patients--pro].
    Tryba M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Dec; 30(8):509-10. PubMed ID: 8580248
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term therapy of gastroduodenal ulcer disease].
    Hahn L
    Z Arztl Fortbild (Jena); 1993; Suppl 1():1-3. PubMed ID: 7901947
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoprotective approach to peptic ulcer therapy: a preliminary dose-finding clinical investigation with triletide.
    Maggi CA; Ferrari D
    Pharmatherapeutica; 1985; 4(3 Spec No):141-5. PubMed ID: 4059295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

  • 10. Behaviour of healed duodenal ulcer on maintenance therapy: age related.
    Gupta AK; Pal LS
    J Assoc Physicians India; 1999 Nov; 47(11):1124-5. PubMed ID: 10862334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antirecurrence treatment of peptic ulcer].
    Papikian MKh; Vaĭstukh SI; Kulabukhov VG
    Ter Arkh; 1980; 52(7):118-21. PubMed ID: 6996196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities of phototherapy in the complex treatment of non-healing peptic ulcers].
    Romanov GA; Sazonov AM; Tereshchenko SG; Koval'kov AI; Lesin EB; Ivanenko TV
    Sov Med; 1991; (4):57-8. PubMed ID: 1871633
    [No Abstract]   [Full Text] [Related]  

  • 13. [The possibilities of using gastrotsepin in treating digestive organ diseases].
    Kalinin AV; Loginov AF; Antokhin EA
    Voen Med Zh; 1993 Jun; (6):52-5. PubMed ID: 8367954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
    Fukuchi S
    Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of recurrent erosive reflux esophagitis].
    Müller P; Simon B
    Fortschr Med; 1997 Oct; 115(30):46-7. PubMed ID: 9453943
    [No Abstract]   [Full Text] [Related]  

  • 18. A method of evaluating drug efficacy by statistical analysis of healing speed of peptic ulcer.
    Kimura K; Ido K; Taniguchi Y; Suzuki T; Yoshida Y; Kawano S; Tsuji S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):916-21. PubMed ID: 8912127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.